PHARMA TECHNOLOGY A/S — Credit Rating and Financial Key Figures
CVR number: 20826746
Åshøjvej 24, 4600 Køge
pharma.technology.ihh@gmail.com
tel: 56638080
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 14 317.76 | 19 151.46 | 20 334.08 | 28 277.40 | 34 739.22 |
Employee benefit expenses | -6 191.42 | -9 226.48 | -11 054.95 | -15 219.47 | -23 040.36 |
Total depreciation | -26.77 | - 117.21 | - 140.47 | - 140.47 | - 140.47 |
EBIT | 8 099.57 | 9 807.77 | 9 138.66 | 12 917.47 | 11 558.39 |
Other financial income | 4.41 | 55.73 | |||
Other financial expenses | -20.79 | -36.58 | -35.10 | -11.99 | -15.23 |
Pre-tax profit | 8 078.78 | 9 771.19 | 9 103.56 | 12 909.88 | 11 598.88 |
Income taxes | -1 777.32 | -2 149.84 | -2 002.83 | -2 840.24 | -2 552.30 |
Net earnings | 6 301.47 | 7 621.35 | 7 100.74 | 10 069.64 | 9 046.57 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 326.73 | 558.37 | 417.90 | 277.43 | 136.96 |
Tangible assets total | 326.73 | 558.37 | 417.90 | 277.43 | 136.96 |
Investments total | |||||
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 8 305.67 | 6 442.16 | 10 076.05 | 13 181.04 | 14 203.70 |
Current amounts owed by group member comp. | 9 873.66 | 9 966.23 | 8 903.02 | 9 090.32 | 9 241.99 |
Current other receivables | 70.55 | 59.11 | 186.07 | 65.81 | 56.16 |
Current deferred tax assets | 12.61 | ||||
Short term receivables total | 18 249.88 | 16 467.50 | 19 165.15 | 22 337.17 | 23 514.46 |
Cash and bank deposits | 348.21 | 1 691.23 | 1 379.33 | 1 381.03 | 2 578.47 |
Cash and cash equivalents | 348.21 | 1 691.23 | 1 379.33 | 1 381.03 | 2 578.47 |
Balance sheet total (assets) | 18 924.82 | 18 717.10 | 20 962.37 | 23 995.63 | 26 229.89 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
Shares repurchased | 6 301.47 | 7 621.35 | 7 100.74 | 10 069.64 | 9 046.57 |
Retained earnings | -6 301.47 | -7 621.35 | -7 100.74 | -10 069.64 | -9 046.57 |
Profit of the financial year | 6 301.47 | 7 621.35 | 7 100.74 | 10 069.64 | 9 046.57 |
Shareholders equity total | 6 801.47 | 8 121.35 | 7 600.74 | 10 569.64 | 9 546.57 |
Provisions | 13.55 | 21.54 | 15.96 | 4.05 | |
Non-current other liabilities | 247.70 | ||||
Non-current deferred tax liabilities | 247.70 | ||||
Non-current liabilities total | 247.70 | 247.70 | |||
Current trade creditors | 4 127.75 | 3 844.95 | 3 607.83 | 2 388.24 | 2 708.76 |
Current owed to group member | 2 000.00 | 2 200.00 | 5 950.00 | 5 200.00 | 7 450.00 |
Other non-interest bearing current liabilities | 5 734.35 | 4 281.56 | 3 787.85 | 5 833.70 | 6 524.56 |
Current liabilities total | 11 862.11 | 10 326.51 | 13 345.68 | 13 421.94 | 16 683.31 |
Balance sheet total (liabilities) | 18 924.82 | 18 717.10 | 20 962.37 | 23 995.63 | 26 229.89 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.